Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sai Samyuktha, Bandaru"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1063-1069 (2024)
Introduction: Multiple myeloma represents a malignant disorder of plasma cells. Extramedullary relapse in multiple myeloma is a rare occurrence, and pericardial involvement stands as an exceedingly uncommon manifestation. Only a few documented cases
Externí odkaz:
https://doaj.org/article/74a44352999c464fb6f1d6ca9e4c069f
Autor:
Ganji Seeta Rama Raju, Eluri Pavitra, Sai Samyuktha Bandaru, Ganji Lakshmi Varaprasad, Ganji Purnachandra Nagaraju, Rama Rao Malla, Yun Suk Huh, Young-Kyu Han
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract HOX transcript antisense intergenic RNA (HOTAIR) is an oncogenic non-coding RNA whose expression is strongly correlated with the tumor grade and prognosis of a variety of carcinomas including breast cancer (BC). HOTAIR regulates various targ
Externí odkaz:
https://doaj.org/article/b312d544bb98484e91fc02a03f64f3ae
Autor:
Ganji Seeta Rama Raju, Eluri Pavitra, Ganji Lakshmi Varaprasad, Sai Samyuktha Bandaru, Ganji Purnachandra Nagaraju, Batoul Farran, Yun Suk Huh, Young-Kyu Han
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-20 (2022)
Abstract The tumor microenvironment (TME) plays a key role in cancer development and emergence of drug resistance. TME modulation has recently garnered attention as a potential approach for reprogramming the TME and resensitizing resistant neoplastic
Externí odkaz:
https://doaj.org/article/2d6266740f5546b69e93125928459e99
Autor:
Sai Samyuktha Bandaru, Gantuya Tserenpil, Sindhusha Veeraballi, Mohammad Nabil Rayad, Neha Merchant, Rajendra Boyilla, Ganji Purnachandra Nagaraju
Publikováno v:
Onco Therapeutics. 9:35-50
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Autor:
Sai Samyuktha Bandaru
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Autor:
Tejasvi, Sunkara, Sai Samyuktha, Bandaru, Rajendra, Boyilla, Rajesh, Kunadharaju, Prithvi, Kukkadapu, Adithya, Chennamadhavuni
Publikováno v:
Cureus.
Pancreatic cancer is the third most common cause of cancer death in the United States and eleventh worldwide. The majority of patients present with advanced disease with five-year overall survival of less than 10%. Traditional chemotherapy has been t